Sentante
PrivateLast Round
Grant
Jul 9, 2024
Total Funding Raised
$9.63M
Company Overview
Sentante is a medical technology company that develops a fully robotic teleoperated system for endovascular interventions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Industrial Robotics, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sentante Comparables
Compare Sentante with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nanoflex Robotics | 92% | |
| Remedy Robotics | 90% | |
| XCath | 89% | |
Sentante Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 9, 2024 | ||||
| Seed | Dec 21, 2023 | ||||
| Grant | Jun 16, 2021 |
Key People
Founding team and executive leadership
Sentante Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Practica Capital | Seed |
| European Regional Development Fund | Grant |
| European Innovation Council Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 23, 2024
Grew 17% QoQ, from 23 to 27 employees.
- Jul 9, 2024
$2.16M grant received from the European Regional Development Fund.
Sentante Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sentante's valuation, stock price, and market status.